Brownlie B E, Rae A M, Walshe J W, Wells J E
Department of Nuclear Medicine, Christchurch Hospital, Christchurch, New Zealand.
Eur J Endocrinol. 2000 May;142(5):438-44. doi: 10.1530/eje.0.1420438.
To report a series of newly diagnosed thyrotoxic patients with concurrent acute psychosis, and to assess the association between the two disorders.
Retrospective study of thyrotoxic patients with associated psychosis ('thyrotoxic psychosis'; TP) requiring inpatient psychiatric care. New Zealand thyrotoxicosis annual incidence figures and first psychiatric admission rates for affective psychosis were utilised to statistically assess the co-occurrence of thyrotoxicosis and affective psychosis.
During the 20-year study period, 18 inpatients (16 women and 2 men), mean age 54 years, with TP were identified. No patient had a past history of thyrotoxicosis, but four had required psychiatric inpatient care many years earlier. Thyrotoxicosis was documented by radioimmunoassay of thyroid hormone levels, and thyroid scintiscan. Psychiatric manifestations were classified using ICD9 criteria.
Thyroid hormone levels were markedly elevated in more than half of our TP patients. All younger patients had Graves' disease, and most older patients toxic nodular goitre. All patients were treated with antithyroid drugs, and all but one subsequently received (131)I therapy. Two patients were not mentally ill when thyrotoxicosis was diagnosed, but suffered major mood swings when thyroid hormone levels were falling. There was no specific psychiatric clinical picture but affective psychoses were commonest - seven depression, seven mania. The other diagnoses were two schizophreniform, one paranoid, and one delirium. Initially, neuroleptic medication was used in all but one patient, and during long-term follow-up (median 11 years) more than half our series had remained well with no further psychiatric problems. Statistical analysis was restricted to thyrotoxic patients with first psychiatric hospital admission for affective psychosis. During the 20-year period, there were nine thyrotoxic patients (95% confidence interval 4.5-17.1) with concurrent affective psychosis requiring first admission, and the calculated expected number was only 0.36. These findings indicate a clear association well above chance co-occurrence.
TP is not a specific clinical picture, but affective psychoses are commonest. Statistical analysis of thyrotoxic patients with concurrent affective psychoses showed an incidence well above chance co-occurrence. It appears that thyrotoxicosis may be a precipitant of acute affective psychosis.
报告一系列新诊断的甲状腺毒症并发急性精神病患者,并评估这两种疾病之间的关联。
对需要住院精神科护理的伴有精神病的甲状腺毒症患者(“甲状腺毒症性精神病”;TP)进行回顾性研究。利用新西兰甲状腺毒症年发病率数据和情感性精神病首次精神科住院率,对甲状腺毒症和情感性精神病的共现情况进行统计学评估。
在20年的研究期间,确定了18例TP住院患者(16名女性和2名男性),平均年龄54岁。所有患者既往均无甲状腺毒症病史,但有4例患者多年前曾需要精神科住院护理。通过甲状腺激素水平放射免疫测定和甲状腺闪烁扫描记录甲状腺毒症情况。使用国际疾病分类第九版(ICD9)标准对精神症状进行分类。
超过半数的TP患者甲状腺激素水平显著升高。所有年轻患者均患有格雷夫斯病,大多数老年患者患有毒性结节性甲状腺肿。所有患者均接受抗甲状腺药物治疗,除1例患者外,其余患者随后均接受了碘-131治疗。2例患者在诊断甲状腺毒症时无精神疾病,但在甲状腺激素水平下降时出现了严重的情绪波动。没有特定的精神科临床表现,但情感性精神病最为常见——7例抑郁症,7例躁狂症。其他诊断包括2例精神分裂症样精神病、1例偏执性精神病和1例谵妄。最初,除1例患者外,所有患者均使用了抗精神病药物,在长期随访(中位时间11年)期间,超过半数的患者情况良好,无进一步的精神问题。统计学分析仅限于首次因情感性精神病入住精神病院的甲状腺毒症患者。在20年期间,有9例甲状腺毒症患者(95%置信区间4.5 - 17.1)并发情感性精神病需要首次入院,而计算出的预期病例数仅为0.36。这些发现表明两者之间存在明显关联,远高于偶然共现。
TP并非一种特定的临床表现,但情感性精神病最为常见。对并发情感性精神病的甲状腺毒症患者进行的统计学分析显示,其发病率远高于偶然共现。甲状腺毒症似乎可能是急性情感性精神病的诱发因素。